Douglas R. Kellogg
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Douglas R. Kellogg has a total of 75 co-authors. Here are the top co-authors by number of shared publications:
- Maria Alcaide-Gavilán
Department of Cell Biology, School of Biology, University of Seville, 41012, Seville, Spain
7 shared publications - Rafael Lucena
Department of Cell Biology, School of Biology, University of Seville, 41012, Seville, Spain
7 shared publications - Ricardo Mendes Leitao
University of California, Santa Cruz
6 shared publications - Akshi Jasani
University of California, Santa Cruz
5 shared publications - Noah Dephoure
Department of Biochemistry, Weill Cornell Medicine, New York, New York, USA
4 shared publications - Robert A. Sommer
University of California, Santa Cruz
4 shared publications
Latest Publications
- 1 June 2026
- Published by American Society for Cell Biology (ASCB) in Molecular Biology of the Cell
- Vol. 37 (6)
A MAP kinase cascade modulates expression of late G1 phase cyclins in budding yeast
Expression of late G1 phase cyclins is the critical molecular event that marks commitment to enter the cell cycle. In budding yeast, late G1 phase cyclins initiate and sustain the growth of a new daughter bud, so their expression also marks the start of a new growth phase during the cell cycle. Expression of late G1 phase cyclins is influenced by nutrient availability—cells growing in poor nutrients progress through the late G1 phase with lower levels of late G1 phase cyclins. However, little is known about how or why nutrients modulate expression of late G1 phase cyclins. Here, we investigated the signals that control expression of the late G1 phase cyclin Cln2. We discovered that nutrients modulate the expression of Cln2 via post-transcriptional mechanisms that influence Cln2 phosphorylation and turnover. Nutrient modulation of Cln2 protein expression requires a TORC2-MAP kinase signaling axis. Expression of Cln2 is closely correlated with bud growth and is required for bud growth. A model that could explain the data is that nutrients modulate Cln2 expression to ensure that the rate of bud growth is matched to the availability of nutrients that support bud growth.
- 1 June 2026
- Published by American Society for Cell Biology (ASCB) in Molecular Biology of the Cell
- Vol. 37 (6)
A MAP kinase cascade modulates expression of late G1 phase cyclins in budding yeast
Expression of late G1 phase cyclins is the critical molecular event that marks commitment to enter the cell cycle. In budding yeast, late G1 phase cyclins initiate and sustain the growth of a new daughter bud, so their expression also marks the start of a new growth phase during the cell cycle. Expression of late G1 phase cyclins is influenced by nutrient availability—cells growing in poor nutrients progress through the late G1 phase with lower levels of late G1 phase cyclins. However, little is known about how or why nutrients modulate expression of late G1 phase cyclins. Here, we investigated the signals that control expression of the late G1 phase cyclin Cln2. We discovered that nutrients modulate the expression of Cln2 via post-transcriptional mechanisms that influence Cln2 phosphorylation and turnover. Nutrient modulation of Cln2 protein expression requires a TORC2-MAP kinase signaling axis. Expression of Cln2 is closely correlated with bud growth and is required for bud growth. A model that could explain the data is that nutrients modulate Cln2 expression to ensure that the rate of bud growth is matched to the availability of nutrients that support bud growth.
- Open Access
A MAP kinase cascade modulates expression of late G1 phase cyclins in budding yeast
Expression of late G1 phase cyclins is the critical molecular event that marks commitment to enter the cell cycle. In budding yeast, late G1 phase cyclins initiate and sustain growth of a new daughter bud, so their expression also marks the start of a new growth phase during the cell cycle. Expression of late G1 phase cyclins is influenced by nutrient availability – cells growing in poor nutrients progress through late G1 phase with lower levels of late G1 phase cyclins. However, little is known about how or why nutrients modulate expression of late G1 phase cyclins. Here, we investigated the signals that control expression of the late G1 phase cyclin Cln2. We discovered that nutrients modulate expression of Cln2 primarily via post-transcriptional mechanisms that influence Cln2 phosphorylation and turnover. Nutrient modulation of Cln2 protein expression requires a TORC2-Pkc1-MAP kinase signaling axis. Furthermore, expression of Cln2 is closely correlated with bud growth and required for bud growth. A model that could explain the data is that nutrients modulate Cln2 expression to ensure that the rate of bud growth is matched to the availability of nutrients that support bud growth.
Open AccessA MAP kinase cascade modulates expression of late G1 phase cyclins in budding yeast
Expression of late G1 phase cyclins is the critical molecular event that marks commitment to enter the cell cycle. In budding yeast, late G1 phase cyclins initiate and sustain growth of a new daughter bud, so their expression also marks the start of a new growth phase during the cell cycle. Expression of late G1 phase cyclins is influenced by nutrient availability – cells growing in poor nutrients progress through late G1 phase with lower levels of late G1 phase cyclins. However, little is known about how or why nutrients modulate expression of late G1 phase cyclins. Here, we investigated the signals that control expression of the late G1 phase cyclin Cln2. We discovered that nutrients modulate expression of Cln2 primarily via post-transcriptional mechanisms that influence Cln2 phosphorylation and turnover. Nutrient modulation of Cln2 protein expression requires a TORC2-Pkc1-MAP kinase signaling axis. Furthermore, expression of Cln2 is closely correlated with bud growth and required for bud growth. A model that could explain the data is that nutrients modulate Cln2 expression to ensure that the rate of bud growth is matched to the availability of nutrients that support bud growth.
- Open Access
- 15 December 2024
- Published by The Company of Biologists in Journal of Cell Science
- Vol. 137 (24)
Casein kinase 1 controls components of a TORC2 signaling network in budding yeast
Tor kinases play diverse and essential roles in control of nutrient signaling and cell growth. These kinases are assembled into two multiprotein complexes known as TORC1 and TORC2. In budding yeast, TORC2 relays nutrient-dependent signals that strongly influence growth rate and cell size. However, the mechanisms that control TORC2 signaling are poorly understood. Activation of TORC2 requires Mss4, a phosphatidylinositol 4-phosphate 5-kinase that recruits and activates downstream targets of TORC2. Localization of Mss4 to the plasma membrane is thought to be controlled by phosphorylation, and previous work has suggested that yeast homologs of casein kinase 1, Yck1 and Yck2 (referred to here collectively as Yck1/2), Control phosphorylation of Mss4. Here, we generated a new analog-sensitive allele of YCK2 and used it to test whether Yck1/2 influence localization of Mss4 or signaling in the TORC2 network. We found that Yck1/2 strongly influence Mss4 phosphorylation and localization, as well as influencing regulation of multiple components of the TORC2 network. However, inhibition of Yck1/2 causes mild effects on the best-characterized signaling axis in the TORC2 pathway, suggesting that Yck1/2 might play a larger role in influencing less well-understood aspects of TORC2 signaling.
- 15 December 2024
- Published by The Company of Biologists in Journal of Cell Science
- Vol. 137 (24)
Open AccessCasein kinase 1 controls components of a TORC2 signaling network in budding yeast
Tor kinases play diverse and essential roles in control of nutrient signaling and cell growth. These kinases are assembled into two multiprotein complexes known as TORC1 and TORC2. In budding yeast, TORC2 relays nutrient-dependent signals that strongly influence growth rate and cell size. However, the mechanisms that control TORC2 signaling are poorly understood. Activation of TORC2 requires Mss4, a phosphatidylinositol 4-phosphate 5-kinase that recruits and activates downstream targets of TORC2. Localization of Mss4 to the plasma membrane is thought to be controlled by phosphorylation, and previous work has suggested that yeast homologs of casein kinase 1, Yck1 and Yck2 (referred to here collectively as Yck1/2), Control phosphorylation of Mss4. Here, we generated a new analog-sensitive allele of YCK2 and used it to test whether Yck1/2 influence localization of Mss4 or signaling in the TORC2 network. We found that Yck1/2 strongly influence Mss4 phosphorylation and localization, as well as influencing regulation of multiple components of the TORC2 network. However, inhibition of Yck1/2 causes mild effects on the best-characterized signaling axis in the TORC2 pathway, suggesting that Yck1/2 might play a larger role in influencing less well-understood aspects of TORC2 signaling.
- Open Access
Mechanisms of growth-dependent regulation of the Gin4 kinase
: Cell cycle progression is dependent upon cell growth. Cells must therefore translate growth into a proportional signal that can be used to determine when there has been sufficient growth for cell cycle progression. In budding yeast, the protein kinase Gin4 is required for normal control of cell growth and undergoes gradual hyperphosphorylation and activation that are dependent upon growth and proportional to the extent of growth, which suggests that Gin4 could function in mechanisms that measure cell growth. However, the molecular mechanisms that drive hyperphosphorylation of Gin4 are poorly understood. Here, we used biochemical reconstitution and genetic analysis to test hypotheses for the mechanisms that drive phosphorylation of Gin4. We ruled out a previous model in which phosphatidylserine delivered to sites of plasma membrane growth binds Gin4 to initiate autophosphorylation. Instead, we show that Elm1, a homolog of the mammalian Lkb1 tumor suppressor kinase, is sufficient to promote hyperphosphorylation of Gin4 in vitro, likely via initiation of Gin4 autophosphorylation. Furthermore, we show that casein kinase I is required for growth-dependent hyperphosphorylation of Gin4 and also for normal regulation of Elm1. Together, these discoveries lead to new insight into mechanisms that link cell cycle progression to cell growth.
Open AccessMechanisms of growth-dependent regulation of the Gin4 kinase
: Cell cycle progression is dependent upon cell growth. Cells must therefore translate growth into a proportional signal that can be used to determine when there has been sufficient growth for cell cycle progression. In budding yeast, the protein kinase Gin4 is required for normal control of cell growth and undergoes gradual hyperphosphorylation and activation that are dependent upon growth and proportional to the extent of growth, which suggests that Gin4 could function in mechanisms that measure cell growth. However, the molecular mechanisms that drive hyperphosphorylation of Gin4 are poorly understood. Here, we used biochemical reconstitution and genetic analysis to test hypotheses for the mechanisms that drive phosphorylation of Gin4. We ruled out a previous model in which phosphatidylserine delivered to sites of plasma membrane growth binds Gin4 to initiate autophosphorylation. Instead, we show that Elm1, a homolog of the mammalian Lkb1 tumor suppressor kinase, is sufficient to promote hyperphosphorylation of Gin4 in vitro, likely via initiation of Gin4 autophosphorylation. Furthermore, we show that casein kinase I is required for growth-dependent hyperphosphorylation of Gin4 and also for normal regulation of Elm1. Together, these discoveries lead to new insight into mechanisms that link cell cycle progression to cell growth.
- Open Access
- 9 May 2024
- Published by Rockefeller University Press in Journal of Cell Biology
- Vol. 223 (8)
Cell growth and nutrient availability control the mitotic exit signaling network in budding yeast
Cell growth is required for cell cycle progression. The amount of growth required for cell cycle progression is reduced in poor nutrients, which leads to a reduction in cell size. In budding yeast, nutrients can influence cell size by modulating the extent of bud growth, which occurs predominantly in mitosis. However, the mechanisms are unknown. Here, we used mass spectrometry to identify proteins that modulate bud growth in response to nutrient availability. This led to the discovery that nutrients regulate numerous components of the mitotic exit network (MEN), which controls exit from mitosis. A key component of the MEN undergoes gradual multisite phosphorylation during bud growth that is dependent upon bud growth and correlated with the extent of growth. Furthermore, activation of the MEN is sufficient to override a growth requirement for mitotic exit. The data suggest a model in which the MEN ensures that mitotic exit occurs only when an appropriate amount of bud growth has occurred.
- 9 May 2024
- Published by Rockefeller University Press in Journal of Cell Biology
- Vol. 223 (8)
Open AccessCell growth and nutrient availability control the mitotic exit signaling network in budding yeast
Cell growth is required for cell cycle progression. The amount of growth required for cell cycle progression is reduced in poor nutrients, which leads to a reduction in cell size. In budding yeast, nutrients can influence cell size by modulating the extent of bud growth, which occurs predominantly in mitosis. However, the mechanisms are unknown. Here, we used mass spectrometry to identify proteins that modulate bud growth in response to nutrient availability. This led to the discovery that nutrients regulate numerous components of the mitotic exit network (MEN), which controls exit from mitosis. A key component of the MEN undergoes gradual multisite phosphorylation during bud growth that is dependent upon bud growth and correlated with the extent of growth. Furthermore, activation of the MEN is sufficient to override a growth requirement for mitotic exit. The data suggest a model in which the MEN ensures that mitotic exit occurs only when an appropriate amount of bud growth has occurred.
- Open Access
- 1 April 2024
- Published by American Society for Cell Biology (ASCB) in Molecular Biology of the Cell
- Vol. 35 (4)
Evidence for novel mechanisms that control cell-cycle entry and cell size
Entry into the cell cycle in late G1 phase occurs only when sufficient growth has occurred. In budding yeast, a cyclin called Cln3 is thought to link cell-cycle entry to cell growth. Cln3 accumulates during growth in early G1 phase and eventually helps trigger expression of late G1 phase cyclins that drive cell-cycle entry. All current models for cell-cycle entry assume that expression of late G1 phase cyclins is initiated at the transcriptional level. Current models also assume that the sole function of Cln3 in cell-cycle entry is to promote transcription of late G1 phase cyclins, and that Cln3 works solely in G1 phase. Here, we show that cell cycle−dependent expression of the late G1 phase cyclin Cln2 does not require any functions of the CLN2 promoter. Moreover, Cln3 can influence accumulation of Cln2 protein via posttranscriptional mechanisms. Finally, we show that Cln3 has functions in mitosis that strongly influence cell size. Together, these discoveries reveal the existence of surprising new mechanisms that challenge current models for control of cell-cycle entry and cell size.
- 1 April 2024
- Published by American Society for Cell Biology (ASCB) in Molecular Biology of the Cell
- Vol. 35 (4)
Open AccessEvidence for novel mechanisms that control cell-cycle entry and cell size
Entry into the cell cycle in late G1 phase occurs only when sufficient growth has occurred. In budding yeast, a cyclin called Cln3 is thought to link cell-cycle entry to cell growth. Cln3 accumulates during growth in early G1 phase and eventually helps trigger expression of late G1 phase cyclins that drive cell-cycle entry. All current models for cell-cycle entry assume that expression of late G1 phase cyclins is initiated at the transcriptional level. Current models also assume that the sole function of Cln3 in cell-cycle entry is to promote transcription of late G1 phase cyclins, and that Cln3 works solely in G1 phase. Here, we show that cell cycle−dependent expression of the late G1 phase cyclin Cln2 does not require any functions of the CLN2 promoter. Moreover, Cln3 can influence accumulation of Cln2 protein via posttranscriptional mechanisms. Finally, we show that Cln3 has functions in mitosis that strongly influence cell size. Together, these discoveries reveal the existence of surprising new mechanisms that challenge current models for control of cell-cycle entry and cell size.
- Open Access
Casein kinase 1 controls components of a TORC2 signaling network in budding yeast
Tor kinases play diverse and essential roles in control of nutrient signaling and cell growth. Tor kinases are assembled into two large multiprotein complexes referred to as Tor Complex 1 and Tor Complex 2 (TORC1 and TORC2). In budding yeast, TORC2 controls a signaling network that relays signals regarding carbon source that strongly influence growth rate and cell size. However, the mechanisms that control TORC2 signaling are poorly understood. Activation of TORC2 requires Mss4, a phosphoinositol kinase that initiates assembly of a multi-protein complex at the plasma membrane that recruits and activates downstream targets of TORC2. Localization of Mss4 to the plasma membrane is controlled by phosphorylation and previous work suggested that yeast homologs of casein kinase 1γ, referred to as Yck1 and Yck2, control phosphorylation of Mss4. Here, we generated a new analog-sensitive allele of YCK2 and used it to test whether Yck1/2 influence signaling in the TORC2 network. We found that multiple components of the TORC2 network are strongly influenced by Yck1/2 signaling.
Open AccessCasein kinase 1 controls components of a TORC2 signaling network in budding yeast
Tor kinases play diverse and essential roles in control of nutrient signaling and cell growth. Tor kinases are assembled into two large multiprotein complexes referred to as Tor Complex 1 and Tor Complex 2 (TORC1 and TORC2). In budding yeast, TORC2 controls a signaling network that relays signals regarding carbon source that strongly influence growth rate and cell size. However, the mechanisms that control TORC2 signaling are poorly understood. Activation of TORC2 requires Mss4, a phosphoinositol kinase that initiates assembly of a multi-protein complex at the plasma membrane that recruits and activates downstream targets of TORC2. Localization of Mss4 to the plasma membrane is controlled by phosphorylation and previous work suggested that yeast homologs of casein kinase 1γ, referred to as Yck1 and Yck2, control phosphorylation of Mss4. Here, we generated a new analog-sensitive allele of YCK2 and used it to test whether Yck1/2 influence signaling in the TORC2 network. We found that multiple components of the TORC2 network are strongly influenced by Yck1/2 signaling.
- Open Access
- 2 November 2023
- Vol. 2023
Expression of oncogenic HRAS G12V causes defects in control of cell size in NIH 3T3 cells.
Severe defects in control of cell size are closely associated with cancer. However, the mechanisms that drive cell size defects in cancer remain unknown and it is unclear whether they are a direct consequence of signals from primary oncogenic drivers or a secondary consequence of mutations that accumulate during evolution of cancer cells. Here, we report that expression of oncogenic HRAS G12V is sufficient to cause cell size defects in NIH 3T3 cells, which suggests that the cell size defects of cancer cells are a direct consequence of primary oncogenic drivers.
- 2 November 2023
- Vol. 2023
Open AccessExpression of oncogenic HRAS G12V causes defects in control of cell size in NIH 3T3 cells.
Severe defects in control of cell size are closely associated with cancer. However, the mechanisms that drive cell size defects in cancer remain unknown and it is unclear whether they are a direct consequence of signals from primary oncogenic drivers or a secondary consequence of mutations that accumulate during evolution of cancer cells. Here, we report that expression of oncogenic HRAS G12V is sufficient to cause cell size defects in NIH 3T3 cells, which suggests that the cell size defects of cancer cells are a direct consequence of primary oncogenic drivers.
- Open Access
Cell growth and nutrient availability control the mitotic exit signaling network in budding yeast
Cell growth is required for cell cycle progression. The amount of growth required for cell cycle progression is reduced in poor nutrients, which leads to a reduction in cell size. In budding yeast, nutrients influence cell size by modulating the duration and extent of bud growth, which occurs predominantly in mitosis. However, the mechanisms are unknown. Here, we used mass spectrometry to identify proteins that mediate the effects of nutrients on bud growth. This led to the discovery that nutrients regulate numerous components of the Mitotic Exit Network (MEN), which controls exit from mitosis. A key component of the MEN undergoes gradual multi-site phosphorylation during bud growth that is dependent upon growth and correlated with the extent of growth. Furthermore, activation of the MEN is sufficient to over-ride a growth requirement for mitotic exit. The data suggest a model in which the MEN integrates signals regarding cell growth and nutrient availability to ensure that mitotic exit occurs only when sufficient growth has occurred.
Open AccessCell growth and nutrient availability control the mitotic exit signaling network in budding yeast
Cell growth is required for cell cycle progression. The amount of growth required for cell cycle progression is reduced in poor nutrients, which leads to a reduction in cell size. In budding yeast, nutrients influence cell size by modulating the duration and extent of bud growth, which occurs predominantly in mitosis. However, the mechanisms are unknown. Here, we used mass spectrometry to identify proteins that mediate the effects of nutrients on bud growth. This led to the discovery that nutrients regulate numerous components of the Mitotic Exit Network (MEN), which controls exit from mitosis. A key component of the MEN undergoes gradual multi-site phosphorylation during bud growth that is dependent upon growth and correlated with the extent of growth. Furthermore, activation of the MEN is sufficient to over-ride a growth requirement for mitotic exit. The data suggest a model in which the MEN integrates signals regarding cell growth and nutrient availability to ensure that mitotic exit occurs only when sufficient growth has occurred.
- 2 August 2023
- Published by Oxford University Press (OUP) in Genetics
- Vol. 225 (2)
Hyperactive Ras disrupts cell size control and a key step in cell cycle entry in budding yeast
Severe defects in cell size are a nearly universal feature of cancer cells. However, the underlying causes are unknown. A previous study suggested that a hyperactive mutant of yeast Ras (ras2G19V) that is analogous to the human Ras oncogene causes cell size defects, which could provide clues to how oncogenes influence cell size. However, the mechanisms by which ras2G19V influences cell size are unknown. Here, we found that ras2G19V inhibits a critical step in cell cycle entry, in which an early G1 phase cyclin induces transcription of late G1 phase cyclins. Thus, ras2G19V drives overexpression of the early G1 phase cyclin Cln3, yet Cln3 fails to induce normal transcription of late G1 phase cyclins, leading to delayed cell cycle entry and increased cell size. ras2G19V influences transcription of late G1 phase cyclins via a poorly understood step in which Cln3 inactivates the Whi5 transcriptional repressor. Previous studies found that yeast Ras relays signals via protein kinase A (PKA); however, ras2G19V appears to influence late G1 phase cyclin expression via novel PKA-independent signaling mechanisms. Together, the data define new mechanisms by which hyperactive Ras influences cell cycle entry and cell size in yeast. Hyperactive Ras also influences expression of G1 phase cyclins in mammalian cells, but the mechanisms remain unclear. Further analysis of Ras signaling in yeast could lead to discovery of new mechanisms by which Ras family members control expression of G1 phase cyclins.
- 2 August 2023
- Published by Oxford University Press (OUP) in Genetics
- Vol. 225 (2)
Hyperactive Ras disrupts cell size control and a key step in cell cycle entry in budding yeast
Severe defects in cell size are a nearly universal feature of cancer cells. However, the underlying causes are unknown. A previous study suggested that a hyperactive mutant of yeast Ras (ras2G19V) that is analogous to the human Ras oncogene causes cell size defects, which could provide clues to how oncogenes influence cell size. However, the mechanisms by which ras2G19V influences cell size are unknown. Here, we found that ras2G19V inhibits a critical step in cell cycle entry, in which an early G1 phase cyclin induces transcription of late G1 phase cyclins. Thus, ras2G19V drives overexpression of the early G1 phase cyclin Cln3, yet Cln3 fails to induce normal transcription of late G1 phase cyclins, leading to delayed cell cycle entry and increased cell size. ras2G19V influences transcription of late G1 phase cyclins via a poorly understood step in which Cln3 inactivates the Whi5 transcriptional repressor. Previous studies found that yeast Ras relays signals via protein kinase A (PKA); however, ras2G19V appears to influence late G1 phase cyclin expression via novel PKA-independent signaling mechanisms. Together, the data define new mechanisms by which hyperactive Ras influences cell cycle entry and cell size in yeast. Hyperactive Ras also influences expression of G1 phase cyclins in mammalian cells, but the mechanisms remain unclear. Further analysis of Ras signaling in yeast could lead to discovery of new mechanisms by which Ras family members control expression of G1 phase cyclins.